LFG
PLSE icon

Larson Financial Group’s Pulse Biosciences PLSE Stock Holding History

Larson Financial Group’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.38K Buy
158
+21
+15% +$496 ﹤0.01% 2829
2026
Q1 		$2.96K Buy
137
+104
+315% +$1.92K ﹤0.01% 2838
2025
Q4 		$453 Sell
33
-149
-82% -$2.32K ﹤0.01% 3143
2025
Q3 		$3.22K Buy
+182
New +$2.88K ﹤0.01% 2519

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Larson Financial Group's PLSE Position: Q2 2026 in Review

Larson Financial Group increased its Pulse Biosciences (PLSE) stake by 15% in Q2 2026, buying an estimated $496 and bringing the position to 158 shares worth $4.38K. The position accounts for ﹤0.01% of the portfolio, ranked #2829.

Larson Financial Group first reported a position in PLSE in Q3 2025 and has held it in 4 quarters since. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Larson Financial Group held 158 shares of Pulse Biosciences worth $4.38K as of Q2 2026.
  • Larson Financial Group bought 21 Pulse Biosciences shares in Q2 2026, an estimated $496.
  • Pulse Biosciences made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2829 holding.
  • Larson Financial Group first reported a position in Pulse Biosciences in Q3 2025 and has held it in 4 quarters since.
  • 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.